The role of generalized trust in COVID-19 vaccine acceptance
Eisnecker PS, Kroh M, Kühne S (2022)
PLOS ONE 17(12): e0278854.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
journal.pone.0278854.pdf
805.54 KB
Autor*in
Einrichtung
Abstract / Bemerkung
Immunization by vaccination is one of the most important tools for fighting the COVID-19 pandemic. Yet in many countries, immunization campaigns have been hampered by vaccine hesitancy within the population. Building on the idea that vaccination decisions are embedded in the broader societal context, we study the role of generalized trust—the belief that most people can generally be trusted—in vaccine acceptance. Immunization campaigns face an inherent collective action problem: As all individuals benefit collectively from high immunization rates regardless of individual contribution, especially those with a low risk of severe COVID infection have an incentive to decide against the (perceived) costs and risks of vaccination. We argue that generalized trust may help to overcome this problem by encouraging the belief that cooperation for the common good is achievable and that those who cooperate are unlikely to be exploited by others. We further argue that the positive effect of generalized trust on vaccination decisions is weaker among individuals who are at higher risk of severe outcomes from the disease, as the collective action problem is less pronounced in this group. To test our predictions, we used data from the SOEP-CoV survey, which queried a representative probability sample of Germany’s population between January and February 2021 on topics connected to the pandemic. Using multiple logistic regression models, and in line with expectations, we found a positive and robust link between generalized trust and the willingness to accept vaccination as soon as offered. However, overall, our examination of heterogeneous effects does not unequivocally support the idea that the role of generalized trust varies according to individual COVID risk.
Erscheinungsjahr
2022
Zeitschriftentitel
PLOS ONE
Band
17
Ausgabe
12
Art.-Nr.
e0278854
Urheberrecht / Lizenzen
eISSN
1932-6203
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Universität Bielefeld gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2967985
Zitieren
Eisnecker PS, Kroh M, Kühne S. The role of generalized trust in COVID-19 vaccine acceptance. PLOS ONE. 2022;17(12): e0278854.
Eisnecker, P. S., Kroh, M., & Kühne, S. (2022). The role of generalized trust in COVID-19 vaccine acceptance. PLOS ONE, 17(12), e0278854. https://doi.org/10.1371/journal.pone.0278854
Eisnecker, Philipp Simon, Kroh, Martin, and Kühne, Simon. 2022. “The role of generalized trust in COVID-19 vaccine acceptance”. PLOS ONE 17 (12): e0278854.
Eisnecker, P. S., Kroh, M., and Kühne, S. (2022). The role of generalized trust in COVID-19 vaccine acceptance. PLOS ONE 17:e0278854.
Eisnecker, P.S., Kroh, M., & Kühne, S., 2022. The role of generalized trust in COVID-19 vaccine acceptance. PLOS ONE, 17(12): e0278854.
P.S. Eisnecker, M. Kroh, and S. Kühne, “The role of generalized trust in COVID-19 vaccine acceptance”, PLOS ONE, vol. 17, 2022, : e0278854.
Eisnecker, P.S., Kroh, M., Kühne, S.: The role of generalized trust in COVID-19 vaccine acceptance. PLOS ONE. 17, : e0278854 (2022).
Eisnecker, Philipp Simon, Kroh, Martin, and Kühne, Simon. “The role of generalized trust in COVID-19 vaccine acceptance”. PLOS ONE 17.12 (2022): e0278854.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
journal.pone.0278854.pdf
805.54 KB
Access Level
Open Access
Zuletzt Hochgeladen
2023-01-05T09:53:30Z
MD5 Prüfsumme
c1ffe2e9501817a644108525f5a6a470
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 36548339
PubMed | Europe PMC
Suchen in